Durable immunity to SARS-CoV-2 in both lower and upper airways achieved with a gorilla adenovirus (GRAd) S-2P vaccine in non-human primates.

MLA

Moliva, Juan I., et al. “Durable Immunity to SARS-CoV-2 in Both Lower and Upper Airways Achieved with a Gorilla Adenovirus (GRAd) S-2P Vaccine in Non-Human Primates.” BioRxiv : The Preprint Server for Biology, Nov. 2023. EBSCOhost, https://doi.org/10.1101/2023.11.22.567930.

APA

Moliva, J. I., Andrew, S. F., Flynn, B. J., Wagner, D. A., Foulds, K. E., Gagne, M., Flebbe, D. R., Lamb, E., Provost, S., Marquez, J., Mychalowych, A., Lorag, C. G., Honeycutt, C. C., Burnett, M. R., McCormick, L., Henry, A. R., Godbole, S., Davis-Gardner, M. E., Minai, M., … Sullivan, N. J. (2023). Durable immunity to SARS-CoV-2 in both lower and upper airways achieved with a gorilla adenovirus (GRAd) S-2P vaccine in non-human primates. BioRxiv : The Preprint Server for Biology. https://doi.org/10.1101/2023.11.22.567930

Chicago

Moliva, Juan I, Shayne F Andrew, Barbara J Flynn, Danielle A Wagner, Kathryn E Foulds, Matthew Gagne, Dillon R Flebbe, et al. 2023. “Durable Immunity to SARS-CoV-2 in Both Lower and Upper Airways Achieved with a Gorilla Adenovirus (GRAd) S-2P Vaccine in Non-Human Primates.” BioRxiv : The Preprint Server for Biology, November. doi:10.1101/2023.11.22.567930.